Center for Law and Biomedical Sciences, University of Utah S. J. Quinney College of Law, Salt Lake City, UT, USA.
Theor Med Bioeth. 2024 Dec;45(6):461-479. doi: 10.1007/s11017-024-09693-z. Epub 2024 Nov 10.
In clinical research, decision-making capacity is often equated with unspecified conceptions of autonomy, and autonomy is often equated with personhood. On this view, the loss of decision-making capacity is seen as a loss of autonomy, and the loss of autonomy subsumes a loss of personhood. An ethical concern arises at the intersection of those philosophical considerations with the legal considerations in informed consent. Because persons with inadequate decision-making capacity cannot provide legally effective consent, enrollment in research can occur only if a surrogate gives permission on the person's behalf. Federal regulations and resulting institutional policies allow permission from surrogates empowered under state law to consent to medical treatment procedures, typically in a hierarchy of legislatively prioritized relationships lacking regard for what the surrogate actually knows about the current research-related values and preferences of the potential subject. As a result, the research enterprise often countenances reliance on surrogates who have no relational or informational basis for an enrollment decision that aligns with the values and preferences of the subject. Arguing from the perspective that losing decision-making capacity does not alter the moral status of persons, and that respect for persons rather than respect for autonomy is the central ethical obligation, I assess the ethical implications of allowing persons with no knowledge of the values and preferences of the potential subject to make enrollment decisions, concluding that reliance on uninformed surrogates is not an ethically defensible approach to enrolling subjects in clinical research.
在临床研究中,决策能力通常等同于对自主权的不明确概念,而自主权通常等同于人格。根据这种观点,决策能力的丧失被视为自主权的丧失,而自主权的丧失包含了人格的丧失。在知情同意的法律考虑与这些哲学考虑的交叉点上,出现了一个伦理问题。因为决策能力不足的人不能提供具有法律效力的同意,所以只有在代表人为其授权的情况下,才能参与研究。联邦法规和由此产生的机构政策允许根据州法律获得授权的代理人同意医疗程序,通常是在立法优先的关系层次结构中,而不考虑代理人实际上对潜在对象的当前研究相关价值观和偏好了解多少。因此,研究机构往往依赖于没有关系或信息依据的代理人来做出与对象的价值观和偏好一致的入组决定。从失去决策能力不会改变人的道德地位的角度出发,并认为尊重人而不是尊重自主权是核心伦理义务,我评估了允许对潜在对象的价值观和偏好一无所知的人做出入组决定的伦理含义,得出的结论是,依赖不知情的代理人不是在临床研究中招募对象的一种合理的伦理方法。